Overview
Voravit Ratanatharathorn is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Ratanatharathorn has been practicing medicine for over 50 years and is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Ratanatharathorn is currently accepting new patients.
His clinical research consists of co-authoring 53 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Regents Of The University Of Michigan
Aki Morikawa is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Morikawa is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is currently accepting new patients.
Henry Ford Health St. John Hospital
Cynthia Vakhariya is a Hematologist and an Oncologist in Southfield, Michigan. Dr. Vakhariya is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Vakhariya is currently accepting new patients.
Oakland Medical Group - Division Of Clinical Hematology & Medical Oncology - Royal Oak
Maryann Shango is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Shango has been practicing medicine for over 15 years and is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are HER-2 Positive Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Pseudomyxoma Peritonei. Dr. Shango is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bone Marrow TransplantDr. Ratanatharathorn isElite. Learn about Bone Marrow Transplant.
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Ratanatharathorn isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Ratanatharathorn isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Graft Versus Host Disease (GvHD)Dr. Ratanatharathorn isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Multiple MyelomaDr. Ratanatharathorn isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Ratanatharathorn isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Ratanatharathorn isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Megakaryoblastic LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Acute Megakaryoblastic Leukemia.
- Acute Myeloblastic Leukemia with MaturationDr. Ratanatharathorn isAdvanced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myelomonocytic LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- Childhood Acute Myeloid LeukemiaDr. Ratanatharathorn isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelogenous Leukemia (CML)Dr. Ratanatharathorn isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Experienced
- Adult T-Cell LeukemiaDr. Ratanatharathorn isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaDr. Ratanatharathorn isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Ratanatharathorn isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Ratanatharathorn isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Ratanatharathorn isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Ratanatharathorn isExperienced. Learn about Breast Cancer.